Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Biosci Biotechnol Biochem ; 64(11): 2380-7, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11193405

ABSTRACT

Qualitative and quantitative analyses of endogenous jasmonoids were done by liquid chromatography/ selected ion monitoring (LC-SIM) using deuterium-labeled compounds as internal standards. To prove the practicality of this way of analyzing the contents of endogenous jasmonoids in plants, the method was used for estimating jasmonoids in potato plants.


Subject(s)
Acetates/analysis , Cyclopentanes/analysis , Glucosides/analysis , Solanum tuberosum/chemistry , Chromatography, Liquid , Deuterium , Reference Standards
2.
J Cardiovasc Pharmacol ; 31(1): 80-4, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9456281

ABSTRACT

We investigated the hemodynamic effects of amrinone and assessed its effects on neurohormonal factors in 15 patients with evolving congestive heart failure with various origins. We serially determined the pulmonary and systemic vascular-resistance indices after amrinone infusion and examined the relation between changes in hemodynamic parameters and changes in concentrations of norepinephrine, atrial natriuretic peptide, angiotensin II, and endothelin-1 in the pulmonary capillary wedge region (PCWR) and in the peripheral veins. Amrinone significantly reduced pulmonary vascular-resistance index (PVRI; Wood x m2) in patients with high PVRI (> or =15) before the infusion, significantly reduced systemic vascular-resistance index (SVRI; Wood x m2) in patients with high SVRI (> or =50) before the infusion, and had little effect on vascular resistances in patients with low PVRI (<15) and low SVRI (<50). The reduction in PVRI was correlated with the reduction in the endothelin-1 level (r = 0.75) in the PCWR, and the reduction in SVRI with norepinephrine level (r = 0.70) in the peripheral veins. The angiotensin II level did not change throughout the study. These findings suggest that amrinone had selective hemodynamic effects on pulmonary and systemic circulations with neurohormonal effects, according to PVRI and SVRI before infusion.


Subject(s)
Amrinone/therapeutic use , Cardiotonic Agents/therapeutic use , Heart Failure/metabolism , Heart Failure/prevention & control , Hemodynamics/drug effects , Vascular Resistance/drug effects , Aged , Angiotensin II/metabolism , Biomarkers , Endothelin-1/metabolism , Female , Heart Failure/physiopathology , Humans , Male , Norepinephrine/metabolism , Statistics as Topic , Vascular Resistance/physiology
3.
Circulation ; 94(9 Suppl): II129-32, 1996 Nov 01.
Article in English | MEDLINE | ID: mdl-8901733

ABSTRACT

BACKGROUND: There is little information about changes in mitral valve function caused by thickening and stiffening of artificial chordae during follow-up. Using serial echocardiographic examination, we evaluated thickening and stiffening of artificial chordae and the effect of those changes on mitral valve function. METHODS AND RESULTS: Between November 1986 and November 1993, 40 patients underwent mitral valve repair with artificial chordae using glutaraldehyde-tanned xenograft pericardium (GTXP) or polytetrafluoroethylene suture (PTFE). Seven GTXP patients and 20 PTFE patients underwent serial echocardiographic examination after surgery and were included in the final analysis. Thickening and stiffening of the artificial chonlae were classified according to echocardiographic changes after surgery: grade 1, no change; grade 2, thickening and/or stiffening without impairment of the motion of the mitral valve leaflet; and grade 3, thickening and stiffening that impaired motion of the mitral valve leaflet. The mean follow-ups in patients with GTXP and PTFE were 6.0 and 3.6 years, respectively. During follow-up, there were 2 GTXP patients with grade 2 thickening and stiffening and 4 patients with grade 3. There were 6 PTFE patients with grade 2 thickening and stiffening and 2 patients with grade 3. Grade 3 occurred earlier in GTXP than in PTFE patients (P < .05). Mitral valve area in GTXP patients decreased from 2.5 +/- 0.4 to 2.1 +/- 0.3 cm2 (P < .05); however, mitral valve area in PTFE patients showed no significant change during follow-up (2.1 +/- 0.4 to 2.0 +/- 0.4 cm2, P = NS). CONCLUSIONS: Although mitral valve repair with artificial chordae is useful, more attention should be paid to mitral valve function resulting from thickening and stiffening of artificial chordae.


Subject(s)
Heart Valve Prosthesis/adverse effects , Mitral Valve/physiopathology , Adult , Aged , Echocardiography , Female , Humans , Male , Middle Aged , Polytetrafluoroethylene , Retrospective Studies
4.
J Am Coll Cardiol ; 27(7): 1693-7, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8636555

ABSTRACT

OBJECTIVES: This study sought to evaluate bioprosthetic valve dysfunction in the tricuspid position by serial Doppler echocardiography. BACKGROUND: Few reports on the long-term results of tricuspid valve replacement with bioprosthetic valves are evaluated by serial Doppler echocardiography. METHODS: Between September 1979 and December 1993, 95 patients underwent tricuspid valve replacement with bioprosthetic valves at our facility. Sixty patients who underwent serial Doppler echocardiographic examination at intervals of at least 2 years after operation were included in the final analysis. These patients were followed up from 1.5 to 13.0 years (mean 5.8 +/- 2.5). RESULTS: The actuarial rates of freedom from bioprosthetic valve stenosis and regurgitation at 10 years were 46% and 51%, respectively. The prevalence of bioprosthetic valve stenosis and regurgitation increased progressively in a linear manner beginning 1 or 2 years after tricuspid valve replacement. Right heart failure developed during follow-up in 20 of the 25 patients with bioprosthetic valve dysfunction. CONCLUSIONS: The long-term durability of bioprosthetic valves in the tricuspid position was substantially lower in our study than that reported in previous studies. Tricuspid bioprosthetic valve dysfunction increased progressively in a linear manner beginning 1 to 2 years after tricuspid valve replacement.


Subject(s)
Bioprosthesis , Echocardiography, Doppler , Heart Valve Prosthesis , Tricuspid Valve/diagnostic imaging , Actuarial Analysis , Adolescent , Adult , Aged , Child , Echocardiography, Doppler, Color , Equipment Failure , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged , Time Factors , Treatment Outcome
5.
Clin Exp Pharmacol Physiol ; 23(5): 379-85, 1996 May.
Article in English | MEDLINE | ID: mdl-8713675

ABSTRACT

1. This study has pharmacologically characterized endothelin (ET) receptor subtype(s) mediating contraction and enhancement of adrenergic contraction in guinea-pig pulmonary artery. Isometric tension of the isolated endothelium-denuded ring preparations was measured in the presence of indomethacin (10(-5) mol/L) and N(G)-nitro-L-arginine methyl ester (L-NAME; 3 x 10(4) mol/L) to exclude a mechanism via endothelium, cyclo-oxygenase-generated eicosanoids and nitric oxide. 2. In the additional presence of tetrodotoxin (TTX; 3 x 10(-7) mol/L), ET-1 (10(-11)-10(-7) mol/L) concentration-dependently contracted the preparations. The rank order of potency to contract the preparations among ET receptor agonists was ET-1, sarafotoxin (STX)6b > ET-3 > IRL 1620, STX 6c. BQ-123 (7 x 10(-7)-7 x 10(-6) mol/L) concentrations-dependently shifted the concentration-contraction curve for ET-1 to the right in a parallel manner. Pretreatment with STX 6c (3 x 10(-7) mol/L for 30 min) did not significantly desensitize contractions to ET-1, ET-3 or IRL 1620 (P > 0.05; t-test, 10 d.f). 3. ET-1 (10(-10)-10(-9) mol/L) and STX 6b (10(-9)-10(-8) mol/L) significantly enhanced the electrical field stimulation-induced contraction in a BQ-123-sensitive manner (P < 0.05: t-test, 24-38 d.f), while ET-3 (10(-11)-10(-8) mol/L) and STX 6c (10(-11)-10(-7) mol/L) did not affect contractions. ET-1 (10(-11) mol/L) significantly enhanced contractions to exogenous noradrenaline in the presence of TTX (3 x 10(-7) mol/L) (P < 0.05; t-test, 16 d.f.). 4. These data indicate that the BQ-123-sensitive ET(A) receptor mediates both contraction and enhancement of adrenergic contractions in the guinea-pig pulmonary artery.


Subject(s)
Catecholamines/pharmacology , Endothelins/pharmacology , Pulmonary Artery/drug effects , Receptors, Endothelin/classification , Receptors, Endothelin/drug effects , Vasoconstriction/drug effects , Animals , Dose-Response Relationship, Drug , Endothelin Receptor Antagonists , Female , Guinea Pigs , In Vitro Techniques , Male , Peptide Fragments/pharmacology , Peptides, Cyclic/pharmacology , Receptors, Endothelin/agonists , Vasoconstrictor Agents/pharmacology , Viper Venoms/pharmacology
6.
Jpn J Antibiot ; 49(1): 95-105, 1996 Jan.
Article in Japanese | MEDLINE | ID: mdl-8851308

ABSTRACT

The effectiveness of fluconazole on deep seated fungal infections associated with hematological disorders was evaluated in a multicenter clinical study. The underlying diseases included acute myeloblastic leukemia, acute lymphocytic leukemia, malignant lymphoma, adult T cell leukemia, multiple myeloma and others. Fluconazole (FLCZ) was administrated 100-400 mg/day intravenously or orally to 79 patients with systemic fungal infections complicated with hematological disorders and it was possible to evaluate clinical efficacies in 60 patients. 27 patients were diagnosed as having determinate systemic fungal infections and 33 patients suspected fungal infections. The clinical efficacies were 81.5% (22/27) in patients with diagnosed fungal infections and 57.6% (19/33) in patients with suspected fungal infections. The overall clinical efficacy was 68.3% (41/60). No side effects such as gastrointestinal symptoms, vascular pain and renal dysfunction were observed in this study. As for abnormal laboratory test, transient increases in GOT, GPT, Al-P, LDH, serum Na, Cl and decrease in serum K were observed in 9 patients (11.4%). These results indicated that FLCZ has a high therapeutic efficacy on deep seated fungal infections in patients with hematological disorders.


Subject(s)
Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Leukemia/complications , Lymphoma/complications , Mycoses/drug therapy , Aged , Aged, 80 and over , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Female , Fluconazole/administration & dosage , Fluconazole/adverse effects , Humans , Male , Multiple Myeloma/complications
7.
J Auton Nerv Syst ; 55(1-2): 115-22, 1995 Oct 05.
Article in English | MEDLINE | ID: mdl-8690844

ABSTRACT

This study investigated involvement of calcitonin-gene-related peptide (CGRP), substance P (SP) and nitric oxide (NO) in transmural nerve stimulation (TNS)-induced non-adrenergic, non-cholinergic (NANC) relaxation in isolated guinea pig anterior mesenteric artery (AMA) and posterior caval vein (PCV). Effects of cyclo-oxygenase-generated eicosanoids were blocked with indomethacin (10(-5) M) and so were adrenergic and cholinergic responses with phentolamine (3 x 10(-6) M), propranolol (10(-6) M) and atropine (10(-6) M). In both vessels precontracted by U-46619, TNS induced relaxation, which was almost completely abolished by capsaicin pretreatment (10(-6) M, 15 minutes). In AMA, a CGRP1 receptor antagonist (human CGRP8-37, 10(-5) M) significantly attenuated the relaxation, while did both human CGRP8-37 (10(-5) M) and neurokinin-1 receptor antagonists (spantide, 2 x 10(-5) M and FK888, 3 x 10(-6) M) in PCV. NG-nitro-L-arginine methyl ester (10(-4) M) did not significantly attenuate either the NANC-or CGRP-induced relaxation in AMA. However, it significantly did attenuate both the NANC-and SP-induced relaxation, and it also considerably attenuated CGRP-induced relaxation although insignificantly, in PCV. Thus, CGRP could be significantly responsible for the NO-independent NANC relaxation in AMA, whereas both CGRP and SP could additionally relax PCV in a NO-dependent manner.


Subject(s)
Muscle Relaxation/physiology , Muscle, Smooth, Vascular/physiology , Neurons, Afferent/physiology , Neuropeptides/physiology , Nitric Oxide/physiology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Capsaicin/pharmacology , Dipeptides/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , Female , Guinea Pigs , In Vitro Techniques , Indoles/pharmacology , Male , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/innervation , NG-Nitroarginine Methyl Ester , Neurons, Afferent/drug effects , Nitric Oxide/antagonists & inhibitors , Prostaglandin Endoperoxides, Synthetic/pharmacology , Receptors, Neurotransmitter/antagonists & inhibitors , Substance P/analogs & derivatives , Substance P/pharmacology , Thromboxane A2/analogs & derivatives , Thromboxane A2/pharmacology , Vasoconstrictor Agents/pharmacology
9.
J Heart Valve Dis ; 4(5): 509-12, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8581194

ABSTRACT

Patients with aortic valvular regurgitation due to non-infectious aortitis are at high risk of valve detachment. In this report, a patient with giant cell aortitis is described, who underwent successful aortic root replacement with a cryopreserved aortic homograft, following two Bentall's type operations that resulted in graft detachment.


Subject(s)
Aortic Valve Insufficiency/surgery , Aortic Valve , Aortitis/complications , Coronary Artery Bypass/methods , Heart Valve Prosthesis , Adult , Aortic Valve/pathology , Aortic Valve/surgery , Aortic Valve Insufficiency/etiology , Aortitis/pathology , Cryopreservation , Giant Cells , Graft Survival , Heart Valve Prosthesis/adverse effects , Heart Valve Prosthesis/methods , Humans , Male , Postoperative Complications , Prosthesis Failure
SELECTION OF CITATIONS
SEARCH DETAIL